Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 371

1.

Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.

Xie M, Xuan B, Shan J, Pan D, Sun Y, Shan Z, Zhang J, Yu D, Li B, Qian Z.

J Virol. 2015 Mar;89(6):3049-61. doi: 10.1128/JVI.03416-14. Epub 2014 Dec 31.

2.

Innate nuclear sensor IFI16 translocates into the cytoplasm during the early stage of in vitro human cytomegalovirus infection and is entrapped in the egressing virions during the late stage.

Dell'Oste V, Gatti D, Gugliesi F, De Andrea M, Bawadekar M, Lo Cigno I, Biolatti M, Vallino M, Marschall M, Gariglio M, Landolfo S.

J Virol. 2014 Jun;88(12):6970-82. doi: 10.1128/JVI.00384-14. Epub 2014 Apr 2.

3.

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.

Tartour K, Appourchaux R, Gaillard J, Nguyen XN, Durand S, Turpin J, Beaumont E, Roch E, Berger G, Mahieux R, Brand D, Roingeard P, Cimarelli A.

Retrovirology. 2014 Nov 25;11:103. doi: 10.1186/s12977-014-0103-y.

4.
5.

Identification of human cytomegalovirus genes important for biogenesis of the cytoplasmic virion assembly complex.

Das S, Ortiz DA, Gurczynski SJ, Khan F, Pellett PE.

J Virol. 2014 Aug;88(16):9086-99. doi: 10.1128/JVI.01141-14. Epub 2014 Jun 4.

6.

Restriction of Human Cytomegalovirus Replication by ISG15, a Host Effector Regulated by cGAS-STING Double-Stranded-DNA Sensing.

Bianco C, Mohr I.

J Virol. 2017 Apr 13;91(9). pii: e02483-16. doi: 10.1128/JVI.02483-16. Print 2017 May 1.

7.
8.

Loss of the Human Cytomegalovirus US16 Protein Abrogates Virus Entry into Endothelial and Epithelial Cells by Reducing the Virion Content of the Pentamer.

Luganini A, Cavaletto N, Raimondo S, Geuna S, Gribaudo G.

J Virol. 2017 May 12;91(11). pii: e00205-17. doi: 10.1128/JVI.00205-17. Print 2017 Jun 1.

9.

Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection.

Xu S, Schafer X, Munger J.

J Virol. 2016 Apr 14;90(9):4346-4356. doi: 10.1128/JVI.00179-16. Print 2016 May.

10.

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.

Compton AA, Bruel T, Porrot F, Mallet A, Sachse M, Euvrard M, Liang C, Casartelli N, Schwartz O.

Cell Host Microbe. 2014 Dec 10;16(6):736-47. doi: 10.1016/j.chom.2014.11.001. Epub 2014 Nov 26.

11.

pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.

Gerlach T, Hensen L, Matrosovich T, Bergmann J, Winkler M, Peteranderl C, Klenk HD, Weber F, Herold S, Pöhlmann S, Matrosovich M.

J Virol. 2017 May 12;91(11). pii: e00246-17. doi: 10.1128/JVI.00246-17. Print 2017 Jun 1.

12.

Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication.

Kapoor A, Forman M, Arav-Boger R.

PLoS One. 2014 Mar 26;9(3):e92704. doi: 10.1371/journal.pone.0092704. eCollection 2014.

14.

Potent Inhibition of Human Cytomegalovirus by Modulation of Cellular SNARE Syntaxin 5.

Cruz L, Streck NT, Ferguson K, Desai T, Desai DH, Amin SG, Buchkovich NJ.

J Virol. 2016 Dec 16;91(1). pii: e01637-16. Print 2017 Jan 1.

15.

IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms.

Wrensch F, Winkler M, Pöhlmann S.

Viruses. 2014 Sep 26;6(9):3683-98. doi: 10.3390/v6093683.

16.

The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells.

Bronzini M, Luganini A, Dell'Oste V, De Andrea M, Landolfo S, Gribaudo G.

J Virol. 2012 Jun;86(12):6875-88. doi: 10.1128/JVI.06310-11. Epub 2012 Apr 11.

17.

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.

Tartour K, Nguyen XN, Appourchaux R, Assil S, Barateau V, Bloyet LM, Burlaud Gaillard J, Confort MP, Escudero-Perez B, Gruffat H, Hong SS, Moroso M, Reynard O, Reynard S, Decembre E, Ftaich N, Rossi A, Wu N, Arnaud F, Baize S, Dreux M, Gerlier D, Paranhos-Baccala G, Volchkov V, Roingeard P, Cimarelli A.

PLoS Pathog. 2017 Sep 28;13(9):e1006610. doi: 10.1371/journal.ppat.1006610. eCollection 2017 Sep.

18.

Human cytomegalovirus protein pUL117 targets the mini-chromosome maintenance complex and suppresses cellular DNA synthesis.

Qian Z, Leung-Pineda V, Xuan B, Piwnica-Worms H, Yu D.

PLoS Pathog. 2010 Mar 19;6(3):e1000814. doi: 10.1371/journal.ppat.1000814.

19.

Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivity.

Gudleski-O'Regan N, Greco TM, Cristea IM, Shenk T.

Cell Host Microbe. 2012 Jul 19;12(1):86-96. doi: 10.1016/j.chom.2012.05.012.

20.

The smallest capsid protein mediates binding of the essential tegument protein pp150 to stabilize DNA-containing capsids in human cytomegalovirus.

Dai X, Yu X, Gong H, Jiang X, Abenes G, Liu H, Shivakoti S, Britt WJ, Zhu H, Liu F, Zhou ZH.

PLoS Pathog. 2013 Aug;9(8):e1003525. doi: 10.1371/journal.ppat.1003525. Epub 2013 Aug 15.

Supplemental Content

Support Center